954.457.3516 |
info@floridahorsemen.org
Follow Us on Social Media:
Home
About the FTHA
Board of Directors
Bylaws
FTHA Committees
FTHA News Bulletin
Photo Gallery
For Horsemen
Controlled Therapeutic Substances
Gulfstream Park Thoroughbred Transition Program
HISA Current Regulations
HISA Registration
Lodging
Benevolence
Benevolence Guidelines
FLORIDA THA REGLAMENTO DE ASISTENCIA
FTHA SCHOLARSHIP PROGRAM 2022
Groom of the Month
Advocacy
Racing Links
Contact
954.457.3516 |
info@floridahorsemen.org
Follow Us on Social Media:
Bulletins
Forms
Benevolence
Home
About the FTHA
Board of Directors
Bylaws
FTHA Committees
FTHA News Bulletin
Photo Gallery
For Horsemen
Controlled Therapeutic Substances
Gulfstream Park Thoroughbred Transition Program
HISA Current Regulations
HISA Registration
Lodging
Benevolence
Benevolence Guidelines
FLORIDA THA REGLAMENTO DE ASISTENCIA
FTHA SCHOLARSHIP PROGRAM 2022
Groom of the Month
Advocacy
Racing Links
Contact
Tag
economy
20
Aug
No, the Super Bowl isn’t going to bring $400M-$600M to Miami
August 20, 2019
FHBPA
Featured Post
,
Florida Political News
,
Floridapolitics.com
,
Headlines
,
Thoroughbred News
“Economic impact” does not equal revenue. The post No, the Super Bowl isn’t going to bring $400M-$600M to Miami appeared first on Florida Politics - Campaigns & Elections. Lobbying & Government..
Read More
Recent Posts
Feb. 3: TRC – Great racetracks we have lost: Hialeah Park – the ‘last word in racetracks and beauty’
Feb. 3: Blood-Horse – Ortiz Jr. Ties Gulfstream Record with Seven-Win Day
Feb. 3: Paulick Report – ARCI Commentary: Potential Regulatory Chaos Necessitates Another Delay Of FTC Action On HISA Rules
Feb. 2: Paulick Report – 1/ST Racing Tour Partners With NBC Sports To Expand Live Horse Racing Coverage
Feb. 1: TDN – Proven Strategies: Looking a Gift Horse in the Mouth
Feb. 1: TDN – Fifth Circuit Judges Deny Motions Related to Rewritten HISA Law
Jan. 27: TDN – FTC Publishes Resubmitted HISA Anti-Doping and Medication Control Rules
Jan. 26: Paulick Report – Congressmen Join National HBPA In Urging FTC To Disapprove HISA’s Medication Rules
